Why realistic testing prevents innovation failure
Great innovation concepts can still fail in market. Learn how realistic testing in competitive contexts prevents costly failures during development.
Personal medical devices, such as auto-injectors for biologics, insulin pens and inhalers, are engineered to allow patients to autonomously deliver their own care. Given their high level of patient involvement, if they are to be successful, these devices must surpass functionality alone to resonate with patients on an emotional level.
In this article published exclusively in WARC, Mike Mabey – our VP Client Solutions Americas – and Ariel Herrlich – our Manager – discussed personal medical devices, such as insulin pens, inhalers and auto-injectors, and the obstacles they need to overcome in order to be successfully implemented.
This paper explores:
Please make sure you're subscribed to WARC to read the entire article or contact Mike if you don't have an access to WARC.
Be the first to receive the latest market research insights, tips from industry peers and exclusive content to help you influence decision behavior.
Great innovation concepts can still fail in market. Learn how realistic testing in competitive contexts prevents costly failures during development.
SKIM named a gold-level pricing consulting leader in 2025 UK rankings—recognized for client impact, expertise, and innovation.
Discover how Alpro create winning sustainability claims that motivate consumers to purchase by connecting to primary choice drivers.
Prevent costly innovation failures and gain a strategic advantage during uncertain times by understanding audience habits first.